Current Neuropharmacology, 2022 · DOI: 10.2174/1570159X19666210924104757 · Published: January 1, 2022
Chronic pain is a widespread neurological problem affecting around 30% of people globally, leading to significant economic and social costs. While scientists have made strides in understanding chronic pain, effectively managing and treating it remains a challenge. Recent research indicates that epigenetic mechanisms, such as DNA/RNA methylation, histone modification, and circular RNA regulation, contribute to the development of chronic pain. Epigenetics involves heritable gene modifications without altering the DNA sequence itself. These modifications play a crucial role in regulating gene expression and are essential in the development of chronic pain. Understanding the functional involvement of epigenetic modifications in chronic pain is fundamentally important. This review focuses on epigenetic modifications like DNA/RNA methylation, histone acetylation, and circular RNA regulation in the spinal cord and dorsal root ganglion (DRG) of rodents experiencing chronic pain. The aim is to provide a brief overview of these epigenetic mechanisms and their involvement in chronic pain.
Modulation of DNMT3a and DNMT3b may offer a promising therapeutic strategy for chronic pain management.
Intervention in the acetylation modification process may identify new drug targets for pain treatment.
Identifying epigenetic modifications in accessible sites like blood or saliva could facilitate non-invasive human studies.